JSI Endorses Two-Drug Initiative To Prevent Maternal, Infant Mortality
Huffington Post: Simple Solutions to Global Problems: How Two Medicines Promise Life for Mothers and Infants in Nigeria
Joel Lamstein, president of JSI and World Education
“…[W]ith support from donors such as USAID, JSI is pioneering a two-drug initiative that uses low-tech and high-impact methods to protect both mother and newborn during and after birth. The first drug, misoprostol, is for the mother to take immediately after delivery. Just three orally ingested pills prevent postpartum hemorrhage, a leading cause of maternal mortality around the world. A second medicine, chlorhexidine, is an easy-to-use antiseptic to replace traditional umbilical cord care. … By ensuring that more newborns live and fewer mothers die, chlorhexidine and misoprostol promise families better futures…” (6/17).